Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Same As
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Requires managed care providers and the medical assistance program shall cover prescription drugs approved by the federal food and drug administration for chronic weight management in adults with obesity with at least one weight-related condition.
Relates to nonhuman primates in testing and research facilities; provides that an animal testing facility no longer in need of a nonhuman primate in its possession shall consider options for and determine the appropriate care of such nonhuman primate, including releasing such nonhuman primate to a certified sanctuary; provides that a higher education research facility that receives public money, or a facility that provides research in collaboration with a higher education facility, shall annually publish certain information on its website concerning nonhuman primates at such facility.
Relates to the definition of drug-related paraphernalia; clarifies that drug-related paraphernalia shall not impact substances that are not considered controlled substances.